Curve Biosciences is creating a DNA based blood test to detect and measure chronic illness throughout the body - the first programs will focus on liver disease
CEO Ritish Patnaik explains the challenges of understanding DNA in the blood for people who have chronic disease, and the idea behind the company's 'Whole Body Atlas' to make sense of it. Curve will start by creating products that track when cirrhosis transitions to its end stages and cancer, and MASH Monitoring.
May 1
From Germany: InnovationLab in Heidelberg aims to spur collaboration between science and industry. It offers entrepreneurs help with labs space, tech transfer, and incubation
InnovationLab Cluster Manager Reza Taale describes all the help InnovationLab can offer. While life scienes is a newer offering, it is one of the strongest focuses today given all of the world class research institutions that exist in the area. InnovationLab hopes to help turn more of the science coming out of them into real world therapies.
Apr 29
From Germany: Heidelberg University has created a unique platform, hei_INNOVATION, that is meant to encourage its students to become entrepreneurs and then help them achieve their goals along the way
Raoul Haschke, Head of hei_INNOVATION, explains the program and walks us around a workspace that is made available to the students to participate.
Apr 28
SLAS 2026: Atinary showed BiotechTV the "Self Driving Lab" it has created in the Seaport that integrates machine learning into the experiment design and optimization process to accelerate science
Co-Founder & CEO Hermann Tribukait explains how integrating AI, robotics, and human expertise can make drug discovery happen at a new speed.
Feb 10
BiotechTV visited South San Francisco based Noetik and saw how they are digitizing tumor samples and using AI to sort through the complexity of cancer biology for drug discovery
Co-Founder and CEO Ron Alfa walked BiotechTV's Ryan Flinn through how machine learning is taking cancer cell biology beyond the microscope.
Oct 30, 2025
Emeryville, CA based Profusa is developing an injectable biosensor that aims to generate biochemistry information for users in real time
Chairman & CEO Ben Hwang describes the idea behind Profusa's approach, and how he believes it delivers more robust and actionable information than purely surface based tools such as the Apple Watch.
Oct 16, 2025
Oxford's OrganOx became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $1.5 billion - here's the revolutionary technology behind it
CEO Craig Marshall describes how the company's "metra" device pumps blood through donor organs (currently livers) in order to extend the...
Oct 10, 2025
.png){kind=logo}